Secondary analyses evaluated ABASAGLAR in patients previously treated with Lantus insulin glargine STOCKHOLM, Sept. 15, 2015 /PRNewswire/ -- Data from secondary analyses of Phase III clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results